Peroxisome proliferator-activated receptor gamma co-activator-1 alpha in depression and the response to electroconvulsive therapy.

Karen M RyanIan PattersonDeclan M McLoughlin

Published in: Psychological medicine (2018)

PGC-1α may represent a novel therapeutic target for the treatment of depression, and be a common link between various pathophysiological processes implicated in depression.

Keyphrases

depressive symptoms
sleep quality
skeletal muscle
nuclear factor
combination therapy
binding protein